Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia.
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
The objective of this study was to determine the effect of delayed therapy on morbidity and mortality associated with nosocomial Staphylococcus aureus bacteremia. The study included all episodes of S. aureus bacteremia that developed >2 days after hospital admission during 1999 to 2001. Classification and regression tree analysis (CART) was used to select the mortality breakpoint between early and delayed treatment. During the 25-month study period, 167 patients met the inclusion criteria. The breakpoint between delayed and early treatment derived using CART was 44.75 hours. On multivariate analysis, delayed treatment was found to be an independent predictor of infection-related mortality (odds ratio, 3.8; 95% confidence interval, 1.3-11.0; P=.01) and was associated with a longer hospital stay than was early treatment (20.2 days versus 14.3 days; P=.05). These findings support the notion that delay of therapy has deleterious effects on clinical outcomes, and efforts should be made to ensure that appropriate therapy is initiated promptly.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Among patients with documented MRSA infections, delays of > 24–48 h until antibiotic administration are associated with increased mortality in some studies [143–147], but not in others [148–154].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [145]
Citations
Cites
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Medical Entomology and Zoology · Cited by 17,248
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
APACHE II: A severity of disease classification system
KNAUS, W. A., DRAPER, E. A., WAGNER, D. P., & ZIMMERMAN, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 13,664
APACHE II-A Severity of Disease Classification System: Reply
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,376 · cited 1×
“non-ICU), presence of a central venous catheter, receipt of total parenteral nutrition (TPN) or mechanical ventilation at the onset of SAB, source of bacteremia, and severity of illness at the onset of SAB (as calculated on the basis of the APACHE II score [17]).”
MethodCDC definitions for nosocomial infections, 1988
Garner, J. S., Jarvis, W. R., Emori, T. G., Horan, T. C., & Hughes, J. M. (1988) · American Journal of Infection Control · doi:10.1016/0196-6553(88)90053-3 · Cited by 5,672
CDC definitions for nosocomial infections
Yangco, B. G. (1989) · American Journal of Infection Control · doi:10.1016/s0196-6553(89)80013-6 · Cited by 3,770 · cited 1×
“Only cases of SAB that occurred 2 days after hospital admission and that met the Centers for Disease Control and Prevention (CDC) criteria for bloodstream infection were included in the analysis [15].”
MethodIbrahim, E. H., Sherman, G., Ward, S., Fraser, V. J., & Kollef, M. H. (2000) · Chest · doi:10.1378/chest.118.1.146 · Cited by 1,779 · cited 1×
“[11] reported that patients who received inappropriate empirical therapy for bloodstream infections in the ICU were at an almost 7-fold higher risk of mortality, compared with patients who received adequate antimicrobial therapy.”
Background(1995) · American Journal of Infection Control · doi:10.1016/0196-6553(95)90104-3 · Cited by 709
The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection
Leibovici, Shraga, Drucker, Konigsberger, Samra, Pitlik, & Pitlik (1998) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1998.00379.x · Cited by 685 · cited 1×
“4%) of 398 patients with SAB did not receive appropriate therapy 48 h after the first positive blood culture result was obtained [9].”
BackgroundBoyce, J. M., Opal, S. M., Chow, J. W., Zervos, M. J., Potter-Bynoe, G., Sherman, C. B., Romulo, R. L., Fortna, S., & Medeiros, A. A. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.5.1148-1153.1994 · Cited by 485 · cited 1×
“The widespread use of vancomycin to treat methicillinresistant Staphylococcus aureus (MRSA) infection has coincided with an increased incidence of vancomycinresistant enterococci (VRE) infections, and numerous studies have suggested an association between vancomycin use and the emergence of VRE [ 1-5].”
Background
Cited by
Items 501–600 of 650
Karpen, R., Murphy, C. V., Reed, E. E., Gerlach, A. T., Cape, K. M., Mellett, J., & Atyia, S. A. (2023) · Hospital Pharmacy · doi:10.1177/00185787231182567 · Cited by 2
Guo, Z., Xu, X., Zhang, G., Wang, X., Tian, X., Li, Y., Li, Q., Chen, D., & Luo, Z. (2024) · European Journal of Pediatrics · doi:10.1007/s00431-024-05624-1 · Cited by 2
“Hence, the varying proportions of MRSA (i.e., Lodise TP' study, Aratani T' study and our study: 61.70%, 56.79%, and 35.63%, respectively) may contribute to the discrepancy in TTAT (i.e., Lodise TP' study, Aratani T' study and our study: 44.75 h, 24 h, and 6.4 h, respectively) [9, 10].”
InfluentialMethicillin Resistant Staphylococcus aureus (MRSA)
Mandal, S., Kundu, A., Borah, D., Ray, M. S., & Mondal, C. (2024) · Wiley eBooks · doi:10.1002/9781394178964.ch12 · Cited by 2
Virk, P., & Tejani, A. M. (2008) · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada · doi:10.3821/1913-701x(2008)141[286:daotoa]2.0.co;2 · Cited by 2
Nosocomial bacteremia: Impact of empirical antimicrobial treatment on the patients’ outcome
Akpabie, A., Duché, C., & Gaudion, M. L. (2008) · Pathologie Biologie · doi:10.1016/j.patbio.2008.10.001 · Cited by 2
Obara, H., SAITOU, J., & Fukuda, H. (2015) · Japanese Journal of Infection Prevention and Control · doi:10.4058/jsei.30.165 · Cited by 2
Early Appropriate Empiric Therapy and Antimicrobial De-Escalation
Hollands, J. M., Micek, S. T., McKinnon, P. S., & Kollef, M. H. (2007) · CRC Press eBooks · doi:10.1201/b15169-13 · Cited by 2
Self-citationTsai, C.-Y., Lee, C., & Chen, I. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06111-w · Cited by 2
“aureus bacteremia was delayed [6], and delayed initiation of appropriate therapy was common for patients with methicillin-resistant S.”
BackgroundБонда, Н. А., Tapalski, D. V., & Стома, И. О. (2021) · Infectious diseases News Opinions Training · doi:10.33029/2305-3496-2021-10-2-54-59 · Cited by 2
Trouillet, J. L., & Chastre, J. E. (2013) · Journal des Anti-infectieux · doi:10.1016/j.antinf.2013.04.003 · Cited by 2
Spectrométrie de masse et hémocultures: un nouvel outil de diagnostic immédiat
Ferroni, A., Suarez, S., Bille, E., Dauphin, B., Béretti, J., & Nassif, X. (2011) · Bio Tribune Magazine · doi:10.1007/s11834-011-0058-4 · Cited by 2
Pitaksontayothin, K., Santimaleeworagun, W., Pongchaidecha, M., Houngsaitong, J., & Srisena, P. (2017) · Asian Biomedicine · doi:10.1515/abm-2018-0011 · Cited by 2
“The initial low concentration of vancomycin may increase the rate of mortality, and MRSA resistance to vancomycin may develop [21, 22].”
BackgroundWilke, M. H., Worf, K., Heinlein, W., Kast, T., & Bodmann, K. ‐. (2020) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-020-00680-5 · Cited by 2
Nutrizione e terapia antibiotica in terapia intensiva cardiologica
Gaudio, R. D., Selmi, V., & Chelazzi, C. (2010) · Giornale italiano di cardiologia · doi:10.1714/568.6740 · Cited by 2
Novel DNA microarray in sepsis diagnostics
Laakso, S. (2013) · Työväentutkimus Vuosikirja · Cited by 2
Ammerlaan, H. (2010) · Utrecht University Repository (Utrecht University) · Cited by 2
Blázquez-Abellán, A. (2016) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya) · Cited by 2
Prosthetic joint infections, biomarkers and antibiotic stewardship
Saeed, K. B. A. (2020) · ePrints Soton (University of Southampton) · Cited by 2
Presentación clínica, etiología y pronóstico de la bacteriemia extrahospitalaria (1998-2011)
Sanz Carabaña, M. D. P. (2015) · Biblos-e Archivo (Universidad Autónoma de Madrid) · Cited by 2
Touat, M. B. (2020) · theses.fr (ABES) · doi:10.70675/3b7fa1e8zd038z469cza345z4a6f15b405a1 · Cited by 2
Ibrahim, O. (2012) · VCU Scholars Compass (Virginia Commonwealth University) · doi:10.25772/xbk8-ms40 · Cited by 2
“selection of initial therapy or the delay in the initiation of appropriate therapy on patient outcomes [60-64].”
BackgroundEvaluation of Positivity Times of Isolates Growing in Blood Cultures
Karpuz, T., Yazısız, H., Özyurt, Ö. K., Çetinkaya, Ö., Özhak, B., Öngüt, G., Çolak, D., & Öğünç, D. (2022) · Flora the Journal of Infectious Diseases and Clinical Microbiology · doi:10.5578/flora.20229805 · Cited by 1
Antibiotics, Antivirals, and Antifungals in Critical Care
Shamshirsaz, A. A., & Vaught, A. “. J. (2024) · Wiley eBooks · doi:10.1002/9781119820260.ch19 · Cited by 1
Tidwong, N., Chanruang, A., Chupradit, S., Parker, S. L., Leelawattanachai, P., Winichakoon, P., & Punyawudho, B. (2024) · Clinical and Translational Science · doi:10.1111/cts.70038 · Cited by 1
“24,25 However, administering conventional dosages during the early stage of treatment often leads to inadequate serum concentrations, resulting in unfavorable clinical outcomes.”
BackgroundNo, T.-H., & Mun, S. J. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-12040-9 · Cited by 1
“Previous studies have reported AAT cut-off time, ranging from 24 to 48 h, beyond which mortality increases, and some studies have even shown no survival benefit associated with early therapy [4–14].”
Boriollo, M. F. G., Oliveira, M. C., da Silva, T. A., da Silva, J. J., de Souza, A. C., Höfling, J. F., & de Sousa, C. P. (2026) · Journal of Oral and Maxillofacial Surgery Medicine and Pathology · doi:10.1016/j.ajoms.2026.01.002 · Cited by 1
Empiric Therapy of Gram-positive Bloodstream Infections and Pneumonia
Bassetti, M., & Villa, G. C. F. (2012) · Springer eBooks · doi:10.1007/978-3-642-25716-2_25 · Cited by 1
“aureus respiratory [43] and bloodstream infections [44], as seen above.”
BackgroundMaximizing positive outcomes for patients with staphylococcal infections
Stahl, J. ‐. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.03056.x · Cited by 1
“at increased risk of mortality [26,27].”
BackgroundLe treaement empirique des bactériémies
Stahl, J. ‐., Pavèse, P., Épaulard, O., Blanc, M., & Brion, J.-P. (2004) · Médecine et Maladies Infectieuses · doi:10.1016/s0399-077x(04)90018-2 · Cited by 1
Antibacterial therapy of adult patients with Sepsis
van Assen, S., Sturm, P., & Pickkers, P. (2010) · Cited by 1
Drwiega, E. N., Nichols, K. R., Kaschak, M., Walter, A., Winn, V., Relich, R. F., & Knoderer, C. A. (2019) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0000000000000772 · Cited by 1
Stefani, M., Musgrave, K., Sevastos, J., Penny, M. J., Day, R. O., & Roberts, D. M. (2023) · Nephrology · doi:10.1111/nep.14198 · Cited by 1
“Therapeutic concentrations should ideally be achieved in the first 24–48 h of treatment to optimize clinical outcome.(3,15) As the duration of vancomycin treatment progressed, patients were more likely to reach or exceed this concentration range.”
BackgroundApplicazione di metodi molecolari nella diagnosi di alcune infezioni batteriche
Storni, E. (2007) · AMS Dottorato Institutional Doctoral Theses Repository (University of Bologna) · doi:10.6092/unibo/amsdottorato/36 · Cited by 1
Prevención y tratamiento de las infecciones adquiridas en relación con la asistencia sanitaria
Gasink, L. B., & Lautenbach, E. (2008) · Clínicas médicas de Norteamérica · Cited by 1
Modeling the Epidemiologic and Economic Impacts of Nosocomial Infection Prevention Strategies
Bailey, R. R. (2011) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 1
Deng, L.-J., Wu, X., Kang, Y., Xu, Y., Zhou, J., Wang, D., & Chen, D. (2013) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.20131037 · Cited by 1
“One report demonstrated that in patients admitted to ICU for sepsis, the adequacy of initial empiric antimicrobial treatment is crucial for outcomes.(13) However, a retrospective study showed that initial antibiotic therapy had no association with mortality and length of hospital stay in hospital-acquired S.”
BackgroundForsblom, E., & Järvinen, A. (2018) · Työväentutkimus Vuosikirja · Cited by 1
Nagao, M., Iinuma, Y., SAITO, T. K., Matsumura, Y., Shirano, M., Matsushima, A., Takakura, S., Ito, I., & Ichiyama, S. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.03156.x · Cited by 1
Impact of Appropriate Antibiotics within One Hour and Patients' Outcome: A Study and Review
Biswas, S., Dasgupta, S., Bhowmick, M. M., Gupta, S., Sinha, S. D., Ghosh, S., Todi, S. K., Dutta, P. R., & Kuotsu, K. (2023) · Journal of Clinical Surgery and Surgical Research · doi:10.59657/2992-9989.brs.23.005 · Cited by 1
Kong, M.-Y., Qin, S.-T., Ling, R. J., Chen, Q., Fu, J., Chen, Y.-J., Zeng, Y., Jiang, D., Lin, G., Zhang, X., et al. (2025) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2025.107154 · Cited by 1
Staphylococcus aureus and healthcare-associated infections
Ekkelenkamp, M. B. (2006) · Utrecht University Repository (Utrecht University) · Cited by 1
Faulhaber, G. A. M., Zavascki, A. P., & Fuchs, S. C. P. C. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.11.1206-b · Cited by 1
Gram-positive hospital acquired infection in the ITU setting
Wilcox, M. H., & Hodgson, G. (2005) · Current Anaesthesia and Critical Care · doi:10.1016/j.cacc.2005.11.012 · Cited by 1
Thomason, J. L., Jain, R., & Limaye, A. P. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ166 · Cited by 1
Ofner, M. (2013) · TSpace (University of Toronto) · Cited by 1
Zasowski, E. J., Trinh, T. D., Atwan, S. M., Merzlyakova, M., Langf, A. M., Bhatia, S., & Rybak, M. J. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa059 · Cited by 1
Self-citationCheng, J., Li, Q., Zhang, G., xu, H., Li, Y., Tian, X., Chen, D., & Luo, Z. (2021) · Research Square · doi:10.21203/rs.3.rs-332633/v1 · Cited by 1
Beyond Perfect Scores: Proof-by-Contradiction for Trustworthy Machine LearningPreprint
Wadduwage, D. N., Jayakody, D., & Zimianitis, L. (2026) · arXiv (Cornell University) · doi:10.48550/arxiv.2601.06704 · Cited by 1
“Misclassifying MRSA as MSSA in clinical practice can cause serious treatment failures, such as longer infections, higher mortality (20–50% increase when therapy is delayed), and faster spread of resistance [7, 27].”
Molecular Approaches to the Diagnosis of Sepsis
Savelkoul, P. H. M., & Peters, R. P. H. (2011) · Molecular Microbiology · doi:10.1128/9781555816834.ch49
Cortés, Ó. I. R., & Rodríguez, J. A. B. (2012) · Repositorio Institucional E-DocUR (Universidad Del Rosario) · doi:10.48713/10336_4243
Studying Effects of Antibiotics
Linkin, D. R., & Lautenbach, E. (2012) · Pharmacoepidemiology · doi:10.1002/9781119959946.ch44
An overview of antibiotic pharmacokinetics
Palazzo, M. G. A. (2007) · Springer eBooks · doi:10.1007/88-470-0407-1_12
The Use of Proteomic Techniques to Study the Physiology and Virulence of Staphylococcus aureus
Rivera, F. E. (2010) · Digital Commons - University of South Florida (University of South Florida)
Margat, E. (2012) · Journal des Anti-infectieux · doi:10.1016/j.antinf.2013.02.003
Treatment of MRSA Infections With Older Molecules: A Reasonable Option for Investigation
Hmouda, H., Salem, C. B., Bouraoui, K., & Jemni, L. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.11.1207-b
Mauch, H. (2009) · Journal of Laboratory Medicine · doi:10.1515/jlm.2009.042et
Audit of the management of Staphylococcus aureus bloodstream infection: gaps to be plugged
Barry, A. S., McNicholas, S., Smyth, E. G., Humphreys, H., & Fitzpatrick, F. (2010) · Journal of Hospital Infection · doi:10.1016/j.jhin.2010.03.003
Staphylococcus aureus bacteraemia - Disease progression and prognosis
Forsblom, E. (2014) · Helda - University of Helsinki Institutional Repository
Gómez, J. R. M., Cuartas, M. C., Molina, O. L., Restrepo, A. C., Marín, G. P., Tobón, J. J. Z., & López, J. A. (2012) · IATREIA · doi:10.17533/udea.iatreia.13938
Ammerlaan, H., Seifert, H., Harbarth, S., Brun‐Buisson, C., Torres, A., Antonelli, M. M., Kluytmans, J. A. J. W., & Bonten, M. J. M. (2010) · Clinical Infectious Diseases · doi:10.1086/650174
Counterinsurgency Doctrine Applied to Infectious DiseasePreprint
Kirkup, B. C. (2014) · doi:10.7287/peerj.preprints.236v1
“Under the traditional ‘war metaphor,’ rapid response is absolutely critical (Heath et al 1996, Rivers et al 2001, Lodise et al 2003, Kang et al 2003, Vince et al 2008).”
Backgroundin patients with blood cultures showing clustered Gram-positive cocci on direct smears 2
Ruimy, R., Dos-Santos, M., Raskine, L., Bert, F., Masson, R., Elbaz, S., Bonnal, C., Lucet, J., Lefort, A., Fantin, B., et al. (2008)
Metastatic nodular pneumonia due to septic embolism: a Staphylococcal infection
Shrestha, S. K., Srivastava, B., Khunjeli, R., & Mohsin, U. R. (2015) · Journal of Advances in Internal Medicine · doi:10.3126/jaim.v3i2.14068
Zhou, R. (2010) · Academic Commons (Stony Brook University)
Staphylococcus aureus: The Persistent Pathogen
Johnston, B., & Conly, J. M. (2003) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2003/274084
Infección por estafilococo aureus metilino resistente adquirido en la comunidad
Jiménez, V. O., Benavides, A. R. G., & Caicedo, Y. (2013) · Univalle Digital Repository (University of Valle)
Camoez, M. (2016) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
When Treating Staph, Anticipating Methicillin Resistance Saves Lives
Zuger, A. (2003) · Journal watch · doi:10.1056/jw200307040000001
Demonstrating the true value of antimicrobial stewardship programs
Chapman, B., & Gonzalez, L. S. (2015) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp150232
von Homeyer, P. (2015) · Advances in medical technologies and clinical practice book series · doi:10.4018/978-1-4666-8603-8.ch019
Turnidge, J. D., & Kotsanas, D. (2008) · Microbiology Australia · doi:10.1071/ma08147
associated with mortality in patients with methicillin-resistant Staphylococcus
Ho, Y.-C., Chang, S., Lin, S.-R., & Wang, W. (2009)
Sturm, P., Kwa, D., Vos, F. J., & Bartels, C. J. M. (2008)
Gelfand, M. S., & Cleveland, K. O. (2015) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0000000000000311
Hamandi, B. (2008) · TSpace (University of Toronto)
Analysis of Vancomycin Plasma Concentrations Following Initial Dosing in Critically Ill Patients
임유진, 전수정, 박상헌, 이은숙, 송경호, 박가영, & 남궁형욱 (2014) · Journal of Korean Society of Health-System Pharmacists · doi:10.32429/jkshp.2014.31.4.002
Cirera, R. G. (2018) · RECERCAT (Consorci de Serveis Universitaris de Catalunya)
Endovascular Infections and Endocarditis
Zingg, W., & Pittet, D. (2019) · Springer eBooks · doi:10.1007/978-1-4939-9034-4_15
A problem solving process for health care.
Msmw (1977) · PubMed
Tucker, K. J., Benning, M., Ryan, K. L., Walraven, C. J., & Jakeman, B. (2020) · Journal of Pharmacy Technology · doi:10.1177/8755122520940710
Ha, K. P. (2019) · Spiral (Imperial College London) · doi:10.25560/80126
Wilke, M. H., Worf, K., Heinlein, W., Kast, T., & Bodmann, K. (2020) · Wiener klinisches Magazin · doi:10.1007/s00740-020-00366-w
Lin, C., Chen, P., Ho, C.-Y., Lee, C.-H., Hsieh, C., Ko, W., & Lee, C. (2021) · Research Square · doi:10.21203/rs.3.rs-225115/v1
“aureus [25], and extended-spectrum beta-lactamase-producing Enterobacteriaceae [26]).”
Systemic infection of Staphylococcus aureus in postnatal woman: a unique finding
Prasanthi, A., Mathews, J. E., Bharathy, M., & Rathore, S. (2021) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20210756
Cheng, J., Li, Q., Zhang, G., Xu, H., Li, Y., Tian, X., Chen, D., & Luo, Z. (2020) · Research Square · doi:10.21203/rs.3.rs-136343/v1
“75 hours for Staphylococcus aureus bacteremia [6].”
Comparison of different scoring tools in early detection of sepsis
Hagerup, T.-A. D., & Fremo, K. K. (2019) · NORA - Norwegian Open Research Archives
Hameed, R., Irrum, N., Saxena, P., & Musameh, M. D. (2021) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20212255
How to break the vicious circle of antibiotic resistances?
Léone, M., & Martin, C. (2008) · Current Opinion in Internal Medicine · doi:10.1097/mci.0b013e32831dabd1
Using antibiotics on various surgeries
Khelifi, I., Mekhaeel, M. S. F., Amine, A. A. A., & Rizk, M. G. H. (2021) · Spravočnik vrača obŝej praktiki (Journal of Family Medicine) · doi:10.33920/med-10-2105-05
Clinical Aspects of Infections Caused by Methicillin-Resistant Staphylococcus aureus
Baršić, B. (2012) · Rad Hrvatske akademije znanosti i umjetnosti Medicinske znanosti
Claessens, Y.-É., André, S., Vinsonneau, C., & Pourriat, J.-L. (2009) · EMC - Anestesia-Rianimazione · doi:10.1016/s1283-0771(09)70288-9
“Le conseguenze deleterie del ritardo nell’instaurazione della terapia antibiotica sono state riportate in molte situazioni cliniche, come la meningite batterica, le infezioni nei pazienti oncologici e le polmoniti comunitarie e nosocomiali [63-69].”
BackgroundKrüger, W. A., & Ludman, A. J. (2014) · Springer eBooks · doi:10.1007/978-3-642-54971-7_4
Claessens, Y.-É., André, S., Vinsonneau, C., & Pourriat, J.-L. (2008) · EMC-Anesthésie réanimation/Encyclopédie médico-chirurgicale. Anesthésie, réanimation · doi:10.1016/s0246-0289(08)44773-4
Corl, K. A., Levy, M. M., Caffrey, A. R., & LaPlante, K. L. (2020) · Critical Care Medicine · doi:10.1097/ccm.0000000000004681
(2004) · Antibiotiques · doi:10.1016/s1294-5501(04)94245-8
Tsai, C.-Y., Lee, C.-H., & Chen, I. (2020) · Research Square · doi:10.21203/rs.3.rs-59403/v2
Claessens, Y.-É., André, S., Vinsonneau, C., & Pourriat, J.-L. (2009) · EMC - Anestesia-Reanimación · doi:10.1016/s1280-4703(09)70459-1
Metadata
- Authors
- Lodise, T. P., McKinnon, P. S., Swiderski, L., & Rybak, M. J.
- Affiliations
- Detroit Receiving Hospital (US)
- Eugene Applebaum College of Pharmacy and Health Sciences (US)
- Corresponding author
- McKinnon, Peggy S.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-06-01
- Volume
- 36
- Issue
- 11
- Pages
- 1418-1423
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2102463930
- Cited by
- 604
- References
- 24
- Citations by year
- 2026: 7 · 2025: 14 · 2024: 15 · 2023: 18 · 2022: 19 · 2021: 24 · 2020: 28 · 2019: 17 · 2018: 18 · 2017: 26 · 2016: 19 · 2015: 40 · 2014: 26 · 2013: 37 · 2012: 31
- FWCI
- 15.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Keywords
- Staphylococcus aureus bacteremia, nosocomial infections, delayed antibiotic treatment, mortality, length of hospital stay, treatment timing, classification and regression trees
- MeSH terms
- Anti-Bacterial Agents, Cross Infection, Female, Humans, Male, Middle Aged, Retrospective Studies, Staphylococcal Infections, Staphylococcus aureus, Cohort Studies, Methicillin Resistance, Bacteremia, Treatment Outcome, Outcome Assessment, Health Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.